Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...
The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...
Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per ...
Genes have to be expressed in the right place, at the time, and at the right levels. Scientists wanted to know more about how ...
Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...
The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer therapeutics market was valued at USD 13.23 ...
Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help ...
Cedar Rapids KCRG-TV on MSN10d
Bill banning mRNA vaccines in Iowa passes subcommitteeA bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...
In a new study published recently in the journal Cell Reports, Yale researchers reveal that mRNA, or messenger RNA, plays a significant role in cell migration, a duty that also dramatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback